nifekalant hydrochloride has been researched along with Asystole in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Kubota, T; Okura, H; Takasugi, N | 1 |
Iacovidou, N; Karlis, G; Lelovas, P; Mentzelopoulos, S; Niforopoulou, P; Papalois, A; Siafaka, I; Xanthos, T | 1 |
Akieda, K; Amino, M; Fujibayashi, D; Fukushima, T; Hashida, T; Higami, S; Inokuchi, S; Kodama, I; Morita, S; Opthof, T; Otsuka, H; Shima, M; Tamura, K; Tanabe, T; Uemura, S; Yoshioka, K | 1 |
Cong, LH; Ji, XF; Li, CS; Wang, S; Yang, L | 1 |
Amino, M; Ban, K; Deguchi, Y; Fujikura, H; Goto, S; Handa, S; Inokuchi, S; Iwase, H; Iwata, O; Marutani, Y; Morita, S; Nakagawa, Y; Shiina, Y; Tanabe, T; Yamamoto, I; Yoshioka, K | 1 |
Amino, M; Deguchi, Y; Ikari, Y; Inokuchi, S; Kodama, I; Matsuzaki, A; Morita, S; Nakagawa, Y; Sugimoto, A; Tanabe, T; Usui, K; Yamamoto, I; Yoshioka, K | 1 |
Ebina, T; Hibi, K; Kimura, K; Kosuge, M; Kosuge, T; Moriwaki, Y; Sugiyama, M; Sumita, S; Suzuki, N; Tahara, Y; Toyama, H; Umemura, S | 1 |
Amino, M; Deguchi, Y; Ikari, Y; Kanda, S; Kodama, I; Kohzuma, K; Matsuzaki, A; Sugimoto, A; Tanabe, T; Usui, K; Yoshioka, K | 1 |
2 trial(s) available for nifekalant hydrochloride and Asystole
Article | Year |
---|---|
Comparative study of nifekalant versus amiodarone for shock-resistant ventricular fibrillation in out-of-hospital cardiopulmonary arrest patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Emergency Service, Hospital; Female; Heart Arrest; Heart Diseases; Humans; Male; Middle Aged; Prognosis; Pyrimidinones; Survival Analysis; Treatment Outcome; Ventricular Fibrillation | 2010 |
Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? : comparative study of out-of-hospital CPA with acidosis and in-hospital CPA without acidosis.
Topics: Acidosis; Aged; Anti-Arrhythmia Agents; Electric Countershock; Epinephrine; Female; Heart Arrest; Humans; Hydrogen-Ion Concentration; Inpatients; Male; Middle Aged; Outpatients; Potassium; Pyrimidinones; Resuscitation; Retrospective Studies; Tachycardia, Ventricular | 2006 |
6 other study(ies) available for nifekalant hydrochloride and Asystole
Article | Year |
---|---|
"Nonsignificant" early repolarization pattern on postresuscitation ECG as a harbinger of impending electrical storm.
Topics: Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Heart Arrest; Humans; Isosorbide Dinitrate; Magnesium; Male; Middle Aged; Potassium Chloride; Pyrimidinones; Vasodilator Agents; Ventricular Fibrillation | 2020 |
Nifekalant Versus Amiodarone in the Treatment of Cardiac Arrest: an Experimental Study in a Swine Model of Prolonged Ventricular Fibrillation.
Topics: Amiodarone; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Disease Models, Animal; Electric Countershock; Epinephrine; Female; Heart Arrest; Heart Rate; Pyrimidinones; Survival Analysis; Swine; Ventricular Fibrillation | 2015 |
Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Arrest; Heart Rate; Male; Pyrimidinones; Swine; Treatment Outcome; Ventricular Fibrillation; Ventricular Function | 2010 |
[Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Drug Resistance; Emergency Medical Services; Epinephrine; Female; Heart Arrest; Humans; Lidocaine; Male; Middle Aged; Prospective Studies; Pyrimidinones; Tachycardia, Ventricular; Ventricular Fibrillation | 2003 |
Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Epinephrine; Female; Heart Arrest; Humans; Lidocaine; Male; Middle Aged; Multivariate Analysis; Pyrimidinones; Retrospective Studies; Survival Rate; Time Factors; Ventricular Fibrillation | 2006 |
Nifekalant hydrochloride administration during cardiopulmonary resuscitation improves the transmural dispersion of myocardial repolarization: experimental study in a canine model of cardiopulmonary arrest.
Topics: Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Disease Models, Animal; Dogs; Heart Arrest; Heart Conduction System; Humans; Pyrimidinones; Tachycardia, Ventricular; Ventricular Fibrillation | 2006 |